The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 8, 2022

Primary Completion Date

February 12, 2023

Study Completion Date

February 12, 2023

Conditions
Breast Cancer
Interventions
OTHER

Focus Group Discussion

Each focus group will consist up to five participants in every session, two sessions each for both low and high risk group. Every FGD sessions will last for 1 to 2 hours and be conducted in Indonesian, and will be recorded. Both groups will be asked the following questions: 1) What is your opinion regarding the clarity of information in the dummy breast cancer risk prediction report?; 2) What is your opinion regarding the completeness of information in the dummy breast cancer risk prediction report?; and 3) What is your impression regarding the results presented in the dummy breast cancer risk prediction report?.

Trial Locations (1)

12930

MRCCC Siloam Hospitals Semanggi, Jakarta

All Listed Sponsors
collaborator

SJH Initiatives

UNKNOWN

collaborator

MRCCC Siloam Hospitals Semanggi

UNKNOWN

lead

Nalagenetics Pte Ltd

INDUSTRY